Skip to main content

Neuronetics, Inc. (STIM)

NASDAQ: STIM · IEX Real-Time Price · USD
5.50
+0.18 (3.38%)
After-hours:Oct 22, 2021 5:56 PM EDT
5.32
-0.14 (-2.56%)
At close: Oct 22, 4:00 PM
Market Cap143.70M
Revenue (ttm)54.52M
Net Income (ttm)-22.48M
Shares Out25.90M
EPS (ttm)-1.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume143,487
Open5.45
Previous Close5.46
Day's Range5.30 - 5.47
52-Week Range4.62 - 22.43
Beta2.49
AnalystsBuy
Price Target13.00 (+144.4%)
Est. Earnings DateNov 1, 2021

About STIM

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of...

IndustryHealth Care Equipment & Supplies
IPO DateJun 28, 2018
Employees161
Stock ExchangeNASDAQ
Ticker SymbolSTIM
Full Company Profile

Financial Performance

In 2020, Neuronetics's revenue was $49.24 million, a decrease of -21.41% compared to the previous year's $62.66 million. Losses were -$27.45 million, -5.48% less than in 2019.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Neuronetics stock is "Buy." The 12-month stock price forecast is 13.00, which is an increase of 144.36% from the latest price.

Price Target
$13.00
(144.36% upside)
Analyst Consensus: Buy

News

CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021

MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, October 12th from Neuronetics, Inc. (NASDAQ: STIM), please note that the Safe Harbor Statement was...

3 days ago - GlobeNewsWire

Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

System Innovations Improve Efficiencies for Healthcare Practices and Patients

3 days ago - GlobeNewsWire

The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $STIM #investors--The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors

1 week ago - Business Wire

Neuronetics Announces Preliminary Revenue for Third Quarter 2021

MALVERN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the q...

1 week ago - GlobeNewsWire

Neuronetics Announces Commercial Agreement with Success TMS

MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the q...

2 weeks ago - GlobeNewsWire

NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch

Efforts feature mental health advocate and expert Dr. Melissa Shepard Efforts feature mental health advocate and expert Dr. Melissa Shepard

2 weeks ago - GlobeNewsWire

UPDATE - New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS

Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers

1 month ago - GlobeNewsWire

New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS

Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers

1 month ago - GlobeNewsWire

Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics

Industry-changing partnership will increase patient access to NeuroStar® Advanced Therapy for Mental Health Industry-changing partnership will increase patient access to NeuroStar® Advanced Therapy for ...

1 month ago - GlobeNewsWire

New Strong Sell Stocks for August 31st

AMWD, CYTK, STIM, OLLI, and THMO have been added to the Zacks Rank #5 (Strong Sell) List on August 31, 2021.

Other symbols:AMWDCYTKOLLITHMO
1 month ago - Zacks Investment Research

New Strong Sell Stocks for August 25th

BEEM, CHRS, KMDA, STIM and PHUN have been added to the Zacks Rank #5 (Strong Sell) List on August 25, 2021

Other symbols:BEEMCHRSKMDAPHUN
1 month ago - Zacks Investment Research

Neuronetics Launches New Website to Meet Patient Demand for Depression Resources

New site enhances the user experience and offers expanded content for depression sufferers New site enhances the user experience and offers expanded content for depression sufferers

2 months ago - GlobeNewsWire

New Strong Sell Stocks for August 6th

AVA, IDN, KOPN, PRIM, and STIM have been added to the Zacks Rank #5 (Strong Sell) List on August 6, 2021.

Other symbols:AVAIDNKOPNPRIM
2 months ago - Zacks Investment Research

Neuronetics Announces Appointment of Megan Rosengarten to its Board of Directors

MALVERN, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the ...

2 months ago - GlobeNewsWire

Neuronetics Stock Plunges As Q2 Earnings Miss Expectations; Underwhelming Q3 Revenue Outlook

Neuronetics Inc (NASDAQ: STIM) reported Q2 EPS loss of $(0.29) lower than $(0.41) posted a year ago, but missing the consensus of $(0.24). Revenue of $14.2 million, missed the consensus of $14.72 millio...

2 months ago - Benzinga

Neuronetics (STIM) Reports Q2 Loss, Misses Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of -20.83% and -3.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Neuronetics Reports Second Quarter 2021 Financial and Operating Results

MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the q...

2 months ago - GlobeNewsWire

7 Stocks to Buy if You Think Alternative Therapies Are the Future

Here are seven stocks to buy if you're optimistic about the potential for alternative therapies to become mainstream treatments. The post 7 Stocks to Buy if You Think Alternative Therapies Are the Futur...

Other symbols:CMPSGTBIFMNMD
2 months ago - InvestorPlace

Neuronetics to Present at the Canaccord Genuity 41st Annual Growth Conference

MALVERN, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the qu...

2 months ago - GlobeNewsWire

Neuronetics (STIM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Neuronetics (STIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Neuronetics to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call

MALVERN, Pa., July 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the q...

3 months ago - GlobeNewsWire

Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers

The redesigned My NeuroStar Resource Center provides user-friendly tools to help practices expand awareness of NeuroStar® Advanced Therapy for Mental Health The redesigned My NeuroStar Resource Center p...

3 months ago - GlobeNewsWire

Neuronetics Set to Join Russell 2000® Index

MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the q...

3 months ago - GlobeNewsWire

Neuronetics (STIM) Soars 39.2%: Is Further Upside Left in the Stock?

Neuronetics (STIM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r...

5 months ago - Zacks Investment Research

Why Neuronetics Blasted 39% Higher Today

The company is experiencing a strong rise in demand.

5 months ago - The Motley Fool